Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress
Launched by STANFORD UNIVERSITY · Jan 24, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Building Resilience at Schools," aims to help teachers and school-aged children in Puerto Rico who are experiencing stress and burnout due to recent natural disasters and the COVID-19 pandemic. The study will explore two types of treatment: a mindfulness program for educators and, for children showing signs of Post Traumatic Stress Disorder (PTSD), this mindfulness training along with a therapy called Cue-Centered Therapy (CCT). The goal is to see how these treatments can improve the mental well-being of educators and support children in developing better emotional skills during tough times.
To participate in the trial, teachers and students at selected schools can sign up, especially if children aged 11-17 have faced traumatic events and show PTSD symptoms. Participants can expect to take part in these mindfulness and therapy sessions, which aim to provide them with tools to manage stress and improve overall mental health. The researchers also hope to learn about the biological factors that may help some individuals be more resilient in the face of adversity, which will guide future mental health support in schools.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Teachers and students at a participating school site, Adults and students/caregivers willing to participate in the study
- 2. For Cue Centered Therapy:
- • 1. Youth aged 11-17 with exposure to at least one Diagnostic Statistical Manual (DSM) 5-defined traumatic event and meeting threshold criteria for posttraumatic symptoms per the University of California Los Angeles (UCLA) PTSD scale.
- • 2. Willingness to participate in therapy
- • 3. Caregiver willing to participate in therapy
- • 4. Perpetrator of the traumatic event is not living in the home with the child
- Exclusion Criteria:
- 1. For the general study and for Cue Centered Therapy:
- • 1. Students doing current trauma-focused interventions with a mental health professional
- • 2. Low cognitive functioning (IQ less than 70)
- • 3. Substance dependence as defined by DSM criteria
- • 4. Autism/Schizophrenia
- • 5. Clinically significant medical illness
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
San Juan, , Puerto Rico
San Juan, , Puerto Rico
San Juan, , Puerto Rico
Patients applied
Trial Officials
Victor Carrion, M.D.
Principal Investigator
John A. Turner, M.D. Professor and Vice-Chair of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Early Life Stress and Resilience Program
Alexander Urban, Ph.D.
Principal Investigator
Associate Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials